[MAXIS] QoQ Quarter Result on 31-Dec-2021 [#4]

Stock
[MAXIS] MAXIS BERHAD
Announcement Date
24-Feb-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
31-Dec-2021 [#4]
Profit Trend
QoQ- -11.08%
YoY- -9.4%
Quarter Report
Latest QR
Upcoming QR
MAXIS's Result
MAXIS's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 2,405,000 2,424,000 2,406,000 2,448,000 2,263,000 2,264,000 2,228,000 5.22%
PBT 470,000 500,000 432,000 384,000 441,000 484,000 453,000 2.48%
Tax -155,000 -171,000 -134,000 -95,000 -116,000 -124,000 -119,000 19.24%
NP 315,000 329,000 298,000 289,000 325,000 360,000 334,000 -3.82%
-
NP to SH 315,000 329,000 298,000 289,000 325,000 360,000 334,000 -3.82%
-
Tax Rate 32.98% 34.20% 31.02% 24.74% 26.30% 25.62% 26.27% -
Total Cost 2,090,000 2,095,000 2,108,000 2,159,000 1,938,000 1,904,000 1,894,000 6.77%
-
Net Worth 6,499,023 6,574,067 6,652,330 6,730,593 6,730,593 7,040,914 7,040,733 -5.19%
Dividend
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Div 391,507 391,313 391,313 391,313 313,050 312,929 312,921 16.09%
Div Payout % 124.29% 118.94% 131.31% 135.40% 96.32% 86.92% 93.69% -
Equity
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Net Worth 6,499,023 6,574,067 6,652,330 6,730,593 6,730,593 7,040,914 7,040,733 -5.19%
NOSH 7,830,148 7,826,271 7,826,271 7,826,271 7,826,271 7,823,238 7,823,037 0.06%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin 13.10% 13.57% 12.39% 11.81% 14.36% 15.90% 14.99% -
ROE 4.85% 5.00% 4.48% 4.29% 4.83% 5.11% 4.74% -
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
RPS 30.71 30.97 30.74 31.28 28.92 28.94 28.48 5.14%
EPS 4.00 4.20 3.80 3.70 4.20 4.60 4.30 -4.70%
DPS 5.00 5.00 5.00 5.00 4.00 4.00 4.00 16.02%
NAPS 0.83 0.84 0.85 0.86 0.86 0.90 0.90 -5.25%
Adjusted Per Share Value based on latest NOSH - 7,826,271
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
RPS 30.70 30.95 30.72 31.25 28.89 28.90 28.44 5.22%
EPS 4.02 4.20 3.80 3.69 4.15 4.60 4.26 -3.78%
DPS 5.00 5.00 5.00 5.00 4.00 3.99 3.99 16.21%
NAPS 0.8297 0.8393 0.8493 0.8592 0.8592 0.8989 0.8988 -5.18%
Price Multiplier on Financial Quarter End Date
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Date 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 -
Price 3.51 3.30 3.93 4.85 4.69 4.39 4.52 -
P/RPS 11.43 10.65 12.78 15.51 16.22 15.17 15.87 -19.63%
P/EPS 87.25 78.50 103.21 131.34 112.94 95.40 105.87 -12.08%
EY 1.15 1.27 0.97 0.76 0.89 1.05 0.94 14.37%
DY 1.42 1.52 1.27 1.03 0.85 0.91 0.88 37.53%
P/NAPS 4.23 3.93 4.62 5.64 5.45 4.88 5.02 -10.77%
Price Multiplier on Announcement Date
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Date 04/11/22 28/07/22 28/04/22 24/02/22 29/10/21 30/07/21 23/04/21 -
Price 3.79 3.62 3.81 4.02 4.67 4.35 4.68 -
P/RPS 12.34 11.69 12.39 12.85 16.15 15.03 16.43 -17.35%
P/EPS 94.21 86.11 100.06 108.86 112.46 94.53 109.62 -9.59%
EY 1.06 1.16 1.00 0.92 0.89 1.06 0.91 10.69%
DY 1.32 1.38 1.31 1.24 0.86 0.92 0.85 34.06%
P/NAPS 4.57 4.31 4.48 4.67 5.43 4.83 5.20 -8.24%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment